Related Experiment Videos
Endothelium-derived hyperpolarizing factor
1Department of Physiology and Biophysics, Mayo Clinic, Rochester, Minn.
Blood Vessels
|January 1, 1990
Summary
Nitric oxide doesn't explain all artery relaxations. Another factor, endothelium-derived hyperpolarizing factor (EDHF), causes hyperpolarization and relaxation by increasing K+ conductance, though its exact nature is unknown.
Area of Science:
- Vascular biology
- Endothelial function
- Smooth muscle physiology
Background:
- Nitric oxide (NO) is a major endothelium-derived relaxing factor (EDRF).
- However, NO cannot account for all endothelium-dependent vascular responses.
- Endothelium-dependent hyperpolarization suggests the involvement of another factor.
Purpose of the Study:
- To investigate the role of endothelium-derived hyperpolarizing factor (EDHF) in vascular responses.
- To characterize the muscarinic receptor subtypes involved in EDHF and EDRF release.
- To explore the mechanism of EDHF-mediated hyperpolarization and relaxation.
Main Methods:
- Studies on isolated arteries.
- Pharmacological characterization of muscarinic receptor subtypes (M1 and M2).
- Measurement of vascular smooth muscle responses (hyperpolarization, relaxation).
Main Results:
- Acetylcholine induces endothelium-dependent hyperpolarization via EDHF release, distinct from EDRF.
- M1 muscarinic receptors mediate EDHF release, while M2 receptors mediate EDRF release.
- EDHF-induced relaxation is linked to increased K+ conductance in vascular smooth muscle.
- The contribution of EDHF varies across different blood vessels.
Conclusions:
- EDHF is a significant mediator of endothelium-dependent vascular relaxation, particularly hyperpolarization.
- Specific muscarinic receptor subtypes (M1 for EDHF, M2 for EDRF) regulate these responses.
- EDHF likely involves a labile arachidonic acid metabolite, but its identity requires further investigation.